- Home
- OGS vs DYN Comparison
OGS vs DYN Comparison
Compare OGS & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGS | DYN |
|---|---|---|
| Founded | 1906 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.8B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OGS | DYN |
|---|---|---|
| Price | $80.41 | $26.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $89.00 | $37.00 |
| AVG Volume (30 Days) | 460.4K | ★ 1.9M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $2,578,005,000.00 | N/A |
| Revenue This Year | $12.51 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $28.90 | ★ N/A |
| Revenue Growth | ★ 42.54 | N/A |
| 52 Week Low | $74.06 | $11.92 |
| 52 Week High | $90.78 | $27.31 |
Technical Indicators
Market Signals| Indicator | OGS | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 58.99 |
| Support Level | $75.93 | $16.45 |
| Resistance Level | $81.90 | $26.96 |
| Average True Range (ATR) | 1.47 | 0.91 |
| MACD | -0.02 | -0.16 |
| Stochastic Oscillator | 48.52 | 59.35 |
Price Performance
Historical ComparisonAbout OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.